DK523676A - Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin - Google Patents

Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin

Info

Publication number
DK523676A
DK523676A DK523676A DK523676A DK523676A DK 523676 A DK523676 A DK 523676A DK 523676 A DK523676 A DK 523676A DK 523676 A DK523676 A DK 523676A DK 523676 A DK523676 A DK 523676A
Authority
DK
Denmark
Prior art keywords
alkyled
thienamycin
derivatives
preparing
procedure
Prior art date
Application number
DK523676A
Other languages
Danish (da)
English (en)
Inventor
B G Christensen
R A Firestone
W J Leanza
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK523676A publication Critical patent/DK523676A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK523676A 1975-11-21 1976-11-19 Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin DK523676A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63429775A 1975-11-21 1975-11-21

Publications (1)

Publication Number Publication Date
DK523676A true DK523676A (da) 1977-05-22

Family

ID=24543224

Family Applications (1)

Application Number Title Priority Date Filing Date
DK523676A DK523676A (da) 1975-11-21 1976-11-19 Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin

Country Status (8)

Country Link
JP (1) JPS5277085A (fr)
CH (1) CH628051A5 (fr)
DE (1) DE2652676A1 (fr)
DK (1) DK523676A (fr)
FR (1) FR2332014A1 (fr)
GB (1) GB1570988A (fr)
NL (1) NL7612937A (fr)
SE (1) SE7612964L (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
EP0008888B1 (fr) * 1978-08-23 1983-09-21 Beecham Group Plc Composés bêta-lactames antibactériens, leur préparation et compositions pharmaceutiques les contenant
EP0017992A1 (fr) * 1979-04-19 1980-10-29 Merck & Co. Inc. Acides 1-carbadéthiapén-2-èm-carboxyliques substitués en position 2 et 6, procédés pour les préparer, compositions pharmaceutiques antibiotiques les contenant et procédé pour préparer des intermédiaires
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
ATE10838T1 (de) * 1980-02-28 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.
JPS5798257A (en) * 1980-12-10 1982-06-18 Sankyo Co Ltd 3,4-disubstituted azetidine-2-one compound and its preparation
EP0062407A1 (fr) * 1981-03-10 1982-10-13 Beecham Group Plc Composés thérapeutiques à cycle bête-lactame
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
ZA834472B (en) * 1982-06-18 1984-03-28 Bristol Myers Co Carbepenem antibiotics
AU2004296261B2 (en) * 2003-12-09 2007-08-23 Choongwae Pharm. Co. A new process for preparation of imipenem

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
CH628051A5 (en) 1982-02-15
SE7612964L (sv) 1977-05-22
JPS5277085A (en) 1977-06-29
FR2332014A1 (fr) 1977-06-17
FR2332014B1 (fr) 1978-11-10
DE2652676A1 (de) 1977-06-02
NL7612937A (nl) 1977-05-24
GB1570988A (en) 1980-07-09

Similar Documents

Publication Publication Date Title
DK494876A (da) Fremgangsmade til fremstilling af piperidinderivater
DK567376A (da) Fremgangsmade til fremstilling af quinazolonderivater
DK562376A (da) Fremgangsmade til fremstilling af ergolinderivater
DK462376A (da) Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater
DK479976A (da) Fremgangsmade til fremstilling af antibiotiske cephalosporinderivater
DK545076A (da) Fremgangsmade til fremstilling af imidazolderivater
DK272676A (da) Fremgangsmade til fremstilling af cephalosporinforbindelser
DK143899C (da) Analogifremgangsmaade til fremstilling af piperazinylpyrazinderivater
DK523676A (da) Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin
DK149194C (da) Fremgangs-maade til fremstilling af (r)-n-phenylalaninderivater
DK324176A (da) Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK528976A (da) Fremgangsmade til fremstilling af indazolderivater
DK298476A (da) Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK494976A (da) Fremgangsmade til fremstilling af purinderivater
DK97376A (da) Fremgangsmade til fremstilling af histidinderivater
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK565676A (da) Fremgangsmade til fremstilling af klavamderivater
DK157401C (da) Analogifremgangsmaade til fremstilling af substituerede n-methylenderivater af thienamycin
DK343976A (da) Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
DK551076A (da) Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK253676A (da) Fremgangsmade til fremstilling af cycloheptathiopenderivater
DK251176A (da) Fremgangsmade til fremstilling af cyklopropanolderivater
DK523276A (da) Fremgangsmade til fremstilling af n-acylderivater af thienamycin
DK140576A (da) Fremgangsmade til fremstilling af 21-hydroxy-16-pregnen-20-on-derivater
DK479876A (da) Fremgangsmade til fremstilling af antibiotiske cephalosporinderivater